Barts Cancer Institute, Queen Mary University of London, Charterhouse Square

London EC1M 6BQ

0 studies enrolling now · 3 studies all time

What they study most

Anemia, Lymphoma, Non-Hodgkin, Peripheral T-cell Lymphoma

Studies at this site

• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
• A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma — Completed
• A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q — Completed